CEACAM5 and neoplasm: Recently, a clinical translational study confirmed the correlation between circulating endocan levels and tumour load in both preclinical and patient models and detected the recurrence in the post-operative phase, even if existing markers such as carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) have been negative.